Cambridge Innovation Capital
Overview
Cambridge Innovation Capital is a venture capital investment firm that backs world-leading life sciences and deep tech companies with an affiliation to the Cambridge ecosystem.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Microbiotica | Oct 2026 | Series C | Co-investor |
| Salience Labs | Oct 2026 | Series B | Co-investor |
| TRIMTECH Therapeutics | Jun 2026 | Seed | Co-investor |
| Trent AI | Apr 2026 | Seed | Lead |
| Immutrin | Mar 2026 | Series A | Co-investor |
For institutional investors. Book with your work email.
Key People
Andrew Williamson
Managing Partner
Rowan Chapman
Non Executive Director
Ian Jauncey
Operating Partner
Paul Anson
Operating Partner
Robert Tansley
Venture Partner
Anne Horgan
Partner
Ian Lane
Partner
Michael Anstey
Partner
Rob Sprawson
Partner CFO
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Cambridge Innovation Capital based?
Cambridge Innovation Capital is headquartered in Cambridge, United Kingdom.
When was Cambridge Innovation Capital founded?
Cambridge Innovation Capital was founded in 2013.
How many portfolio companies does Cambridge Innovation Capital have?
Cambridge Innovation Capital has 35 portfolio companies in Caplight's dataset.
What are some companies in Cambridge Innovation Capital's portfolio?
Recent investments visible on Caplight include Microbiotica, Salience Labs, TRIMTECH Therapeutics, Trent AI, Immutrin.
What was Cambridge Innovation Capital's most recent investment?
Cambridge Innovation Capital's most recent investment on Caplight was in Microbiotica in 2026.
What sectors does Cambridge Innovation Capital focus on?
Cambridge Innovation Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Frontier & Industrial Tech, Enterprise Software, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Frontier & Industrial Tech, Cybersecurity, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Energy & Sustainability, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Enterprise Software, Telecommunications & Networking, FinTech, Frontier & Industrial Tech, Frontier & Industrial Tech, Mobility, Transportation & Logistics, Enterprise Software, AI, Data & Cloud Infrastructure, Mobility, Transportation & Logistics, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Energy & Sustainability, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, Enterprise Software, Frontier & Industrial Tech, Enterprise Software, Enterprise Software, Energy & Sustainability, AI, Data & Cloud Infrastructure, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Cambridge Innovation Capital focus on?
Cambridge Innovation Capital typically invests at the Early stage.
What is Cambridge Innovation Capital's AUM?
Cambridge Innovation Capital's assets under management are estimated between $500.0M and $1.0B.